ConductScience.org, home

Paper36976157

Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis.

Wilson L and 4 others. Transl Vis Sci Technol, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis. Papers, record 36976157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36976157

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis.
PubMed
Journal
Transl Vis Sci Technol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson LLeslie
2Lewis KEKatherine E
3Evans LSLawrence S
4Dillon SRStacey R
5Pepple KLKathryn L

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Autoimmune DiseasesMajor topic
UveitisMajor topic
Rats
Humans
Animals
CD28 Antigens
Rats, Inbred Lew
T-Lymphocytes
Recombinant Fusion Proteins

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 DK017047NIDDK NIH HHSUnited StatesP30DK017047PubMed and NIHNIH RePORTER
P30 EY001730NEI NIH HHSUnited StatesP30EY001730PubMed and NIHNIH RePORTER

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133823429A review on applications of abatacept in systemic rheumatic diseases.Int Immunopharmacol2021https://conductscience.org/library/papers/33823429PubMed
235498797Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience.Front Pediatr2022https://conductscience.org/library/papers/35498797PubMed
327633826Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.J Rheumatol2016https://conductscience.org/library/papers/27633826PubMed
419748676Methotrexate for ocular inflammatory diseases.Ophthalmology2009https://conductscience.org/library/papers/19748676PubMed
532459545Effect of In Vivo Expansion of Regulatory T Cells with IL-2/anti-IL-2 Antibody Complex Plus Rapamycin on Experimental Autoimmune Uveoretinitis.Ocul Immunol Inflamm2021https://conductscience.org/library/papers/32459545PubMed
611046032Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.J Immunol2000https://conductscience.org/library/papers/11046032PubMed
725178807Long-term clinical outcome and causes of vision loss in patients with uveitis.Ophthalmology2014https://conductscience.org/library/papers/25178807PubMed
825774330One-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis.Transl Vis Sci Technol2015https://conductscience.org/library/papers/25774330PubMed
928248972Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.PLoS One2017https://conductscience.org/library/papers/28248972PubMed
1020042178Mycophenolate mofetil for ocular inflammation.Am J Ophthalmol2010https://conductscience.org/library/papers/20042178PubMed
1124917273A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.Ophthalmology2014https://conductscience.org/library/papers/24917273PubMed
1234632541Intraocular therapy in noninfectious uveitis.J Ophthalmic Inflamm Infect2021https://conductscience.org/library/papers/34632541PubMed
1326971048Topical ocular dexamethasone decreases intraocular pressure and body weight in rats.J Negat Results Biomed2016https://conductscience.org/library/papers/26971048PubMed
1411581203Relationship between aqueous humor protein level and outflow facility in patients with uveitis.Invest Ophthalmol Vis Sci2001https://conductscience.org/library/papers/11581203PubMed
156971281Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution.Invest Ophthalmol Vis Sci1981https://conductscience.org/library/papers/6971281PubMed
1632564920Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.Ophthalmology2020https://conductscience.org/library/papers/32564920PubMed
1712084735Visual impairment and blindness in Europe and their prevention.Br J Ophthalmol2002https://conductscience.org/library/papers/12084735PubMed
1832886537Definition of Uveitis Refractory to Treatment: A Systematic Review in the Absence of a Consensus.Ocul Immunol Inflamm2022https://conductscience.org/library/papers/32886537PubMed
1912876557Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.Nat Rev Immunol2003https://conductscience.org/library/papers/12876557PubMed
203106257Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes.Invest Ophthalmol Vis Sci1987https://conductscience.org/library/papers/3106257PubMed

See all 68 referencesDownload CSV of references

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36976157

GET https://conductscience.org/api/papers/v1/36976157/references?page=2